NYSE$BLCO
Bausch + Lomb Corp · Q2 2022 earnings
Q2 2022 earnings · · Investor relations
Briefing
Second quarter results for 2022 announced, demonstrating the strength of the integrated eye care platform.
Bausch + Lomb reported $941 million in revenues for Q2 2022, a 1% increase compared to Q2 2021. GAAP Net Income was $5 million. The company reaffirmed its 2022 full-year revenue and adjusted EBITDA guidance ranges.
- Revenues of $941 Million
- GAAP Net Income of $5 Million
- Adjusted EBITDA (non-GAAP) of $182 Million
- GAAP Cash Flow from Operations of $156 Million
Headline financials
Revenue & EPS history
Bausch + Lomb · Revenue · Quarterly
$941M
Revenue by segment
Bausch + Lomb · $941M total across 3 segments · Q2 2022
- Vision Care$589M+5.9%62.6%
- Surgical$184M-0.5%19.6%
- Pharmaceuticals$168M-13.0%17.9%
Forward guidance
Bausch + Lomb maintained guidance for the full year of 2022 as follows: •Full-year revenue range of $3.75 – $3.80 billion, reflecting anticipated 4-5% organic1,2 growth •Full-year Adjusted EBITDA (non-GAAP)1 range of $740 – $780 million
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 18 quarterly earnings reports · overlaid with Q2 2022
-1.0%
Avg return
Earnings day
-1.8%
Avg return
5 days after
-1.0%
Avg return
30 days after
43%
9 / 21 earnings
Positive
+18.7%
Q4 2023
Best reaction
-15.7%
Q1 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -1.8% | +2.9% | -1.0% | |
| Q4 2025 | +0.2% | +1.5% | -11.3% | |
| Q3 2025 | +2.1% | +0.3% | +6.5% | |
| Q1 2025 | -15.7% | -17.1% | -16.4% | |
| Q4 2024 | -0.3% | -3.3% | -4.8% | |
| Q3 2024 | -2.3% | -4.3% | -4.5% | |
| Q2 2024 | -0.1% | -8.7% | -2.6% | |
| Q1 2024 | -4.7% | -0.7% | +5.5% | |
| Q4 2023 | +18.7% | +15.7% | +10.8% | |
| Q3 2023 | +4.6% | +2.9% | -4.3% | |
| Q2 2023 | -2.5% | -3.4% | -7.2% | |
| Q1 2023 | +0.1% | +4.6% | +4.4% | |
| Q4 2020 | +0.4% | -3.7% | -14.1% | |
| Q4 2022 | +0.4% | -3.7% | -14.1% | |
| Q3 2022 | -4.9% | +5.6% | +7.9% | |
| Q3 2021 | -4.9% | +5.6% | +7.9% | |
| Q2 2022 | +4.7% | +6.3% | +1.2% | |
| Q2 2021 | +4.7% | +6.3% | +1.2% | |
| Q1 2022 | -6.8% | -14.6% | +5.0% | |
| Q4 2021 | -6.8% | -14.6% | +5.0% | |
| Q1 2021 | -6.8% | -14.6% | +5.0% | |
| Q3 2020 | — | — | — | |
| Q2 2020 | — | — | — | |
| Q1 2020 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro